medigraphic.com

2006, Number 4

<< Back Next >>

Enf Infec Microbiol 2006; 26 (4)

Clinical and laboratory, correlatiom from cerebrospinal fluid procoagulant activity in bacterial meningoencephalytis

Arrevillaga BG, Gómez GB

Language: Spanish
References: 48
Page: 115-122
PDF size: 86.74 Kb.


ABSTRACT

Epidemiological, clinical and in animal models studies associate primary viral infection with secondary bacterial infections. Biochemical and molecular mechanisms involved on viral bacterial interactions are not well understood, albeit studies on respiratory virus and bacteria co-infections date from the twenty years of last century. Alterations in the infected cell by the virus direct and/or indirect modify the host bactericidal activities. Host cell bactericidal processes start as response to the host recognition of microbial components, known as pathogen associated molecular patterns ((PAMPs) through membrane recognition receptors such as toll like (TLR). PAMPs and TLR interactions activate transduction signals which induce the expression of genes involved in the immune response against bacteria. Control of viral primary infection and the secondary bacterial infection is a multifactor process and requires in tune interaction between host cell, bacteria and virus which easily can be disturbed by co-infection. Here we review cell host changes due to respiratory virus and bacteria that favors co-infection.


REFERENCES

  1. Abas AK y Lichtman AH. Inmunología celular y molecular. Elsevier, Madrid, 2004, pp. 241-345.

  2. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-653.

  3. Avadhanula V, Rodríguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC, Adderson EE. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol 2006; 80: 1629-1636.

  4. Avadhanula V, Rodríguez CA, Klett GC, Bakaletz LO, Adderson EE. Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. J. Virol 2006; 74: 830-838.

  5. Beadling C, Cundell DR, Sandros J, Pearce BJ, Idanpaan- Heikkila I, Rosenow C, Masure HR. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Spellerberg. Mol. Microbiol 1996; 19: 803-813.

  6. Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Curr Opin Infect Dis. 2004, 17: 185-191.

  7. Bernard M y Babior JM. NADPH oxidase: An Update. Blood 1999; 93: 1464-1476.

  8. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2: 907-916.

  9. Bulut Y, Guven M, Otlu B, Yenisehirli G, Aladag I, Eyibilen A, Dogru S. Acute otitis media and respiratory viruses. Eur. J. Pediatr 2006 (en prensa).

  10. Chi B et al. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. Virology 2006; 80: 5032-5040.

  11. Conron M, Andreakos E, Pantelidis P, Smith C, Beynon HL, Dubois RM, Foxwel BM. Nuclear factor-kappaB activation in alveolar macrophages requires IkappaB kinase-beta, but not nuclear factor-kappaB inducing kinase. Am. J. Respir. Crit. Care. Med 2002; 165: 996-1000.

  12. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol 2004; 10: 820-832.

  13. Fritz JH y Girardin SE. How Toll-like receptors and Nodlike receptors contribute to innate immunity in mammals. J. Endotoxin Res 2005; 11: 390-394

  14. Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006; 344: 119-130.

  15. Hament JM, Aerts PC, Fleer A, van Dijk H, Harmsen T, Kimpen JL, Wolfs TF. Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model. Pediatr. Res 2005; 58: 1198-1203.

  16. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review.FEMS. Immunol. Med. Microbiol 1999; 26: 189-195.

  17. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am. J. Dis. Child 1991; 146: 1018-1019.

  18. Higashimoto Y et al. Effect of the adenovirus E1A gene on nitric oxide production in alveolar epithelial cells. Clin. Microbiol. Infect 2005; 11: 644-650.

  19. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002; 20: 3068-3087.

  20. Janew WL, Dietlein F, Low G, Burch and W Mogabgab. Bronchotracheal response in human influenza. Arch. Intern. Med 1960; 108: 376-388.

  21. Janeway CA Jr. How the immune system protects the host from infection. Microbes Infect 2001; 13: 1167-1171.

  22. Jansen HM, Lutter R, van der Poll T. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am. J. Physiol. Lung. Cell. Mol. Physiol 2005; 290: L194-199

  23. Jiang Z, Nagata N, Molina E, Bakaletz LO, Hawkins H, Patel JA. Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect. Immun 1999; 67:187-192.

  24. Lehtinen P, Jartti T, Virkki R, Vuorinen T, Leinonen M, Peltola V, Ruohola A, Ruuskanen O. Bacterial coinfections in children with viral wheezing. Eur. J. Clin. Microbiol. Infect. Dis. 2006; 25: 463-469.

  25. Loosli CG. Influenza and the interaction of viruses and bacteria in respiratory infections. Medicine (Baltimore) 1973; 52: 369-384.

  26. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 2003; 187: 1000-1009.

  27. McCullers JA, Tuomanen EI. Molecular pathogenesis of pneumococcal pneumonia. Front. Biosci 2001; 6: D877-889.

  28. McCullers. JA. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev 2006; 19: 571-582.

  29. Medzhitov R y Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol 1997; 9: 4- 9.

  30. Monobe H, Ishibashi T, Nombra Y, Shinogami M, Yano J. Role of respiratory viruses in children with acute otitis media Int J Pediatr Otorhinolaryngol 2003; 67: 8016.

  31. Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol 2004; 75: 749-755.

  32. Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell. 2006; 124: 715-727.

  33. Plotkowski MC, Bajolet-Laudinat O y Puchelle E. Cellular mechanisms of bacterial adhesion to respiratory mucosa. Eur. Respir. J. 1993 ; 6: 903-916.

  34. Ramphal R, Small P, Shands J, Fischschweiger W y Small P. Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or endotracheal intubation. Infect. Immun 1980; 27: 614-619.

  35. Raza MW, Blackwell CC, Elton RA, Weir DM. Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus. J. Med. Microbiol 2000; 49: 227-233.

  36. Raza MW, El Ahmer OR, Ogilvie MM, Blackwell CC, Saadi AT, Elton RA, Weir DM. Infection with respiratory syncytial virus enhances expression of native receptors for non-pilate Neisseria meningitidis on HEp-2 cells. FEMS Immunol. Med. Microbiol 1999; 23: 115-124.

  37. Reddy MS, Bernstein JM, Murphy TF, Faden HS. Binding between outer membrane proteins of nontypeable Haemophilus influenzae and human nasopharyngeal mucin. Infect. Immun 1996; 64: 1477-1479.

  38. Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol 2006; 533: 240-252.

  39. Sagai S et al. Relationship between respiratory syncytial virus infection and acute otitis media in children. Auris. Nasus. Larynx 2004; 31: 341-345.

  40. Selinger DS, Reed WP, McLaren LC. Model for studying bacterial adherence to epithelial cells infected with viruses. Infect. Immun 1981; 32: 941-944.

  41. Sinaniotis CA. Viral pneumonia in children: incidence and etiology. Paediatr. Respir. Rev 2004; 5 Suppl A: S197-200.

  42. Slifka MK, Homann D, Tishon A, Pagarigan R, Oldstone MB. Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. J. Clin. Invest 2003; 111: 805-810.

  43. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol 2004; 78: 4363-4369. Erratum in: J. Virol 2005; 78: 6705.

  44. Suzuki K, Bakaletz LO. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun 1994; 62: 1710-1718.

  45. Uematsu S, Akira S. Toll-like receptors and innate immunity. Mol. Med 2006; Aug 10 (en prensa).

  46. Van der Sluijs KF et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol 2006; 290: L194-199.

  47. Weber F, Kochs G, Haller O. Inverse interference: how viruses fight the interferon system. Viral. Immunol 2004; 17: 498-515.

  48. Wright PF, Thompson J and Karzon DT. Differing virulence of H1N1 and H3N2 influenza strains. Am. J. Epidemiol 1980; 112: 814-819.




2020     |     www.medigraphic.com